BOAI NKY MEDICAL HOLDINGS LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 22.19 CNY | +1.51% |
|
-0.27% | +23.00% |
| Apr. 26 | Boai NKY Medical Holdings Ltd. Proposes Final Cash Dividend for 2023 | CI |
| Apr. 25 | Boai NKY Medical Holdings Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 2,997 | 5,289 | 4,426 | 7,491 | 7,477 | 5,551 |
| Enterprise Value (EV) 1 | 3,412 | 5,945 | 4,980 | 6,226 | 6,973 | 5,286 |
| P/E ratio | 33.5 x | 36.4 x | 97.9 x | 24.8 x | 28.5 x | 11.9 x |
| Yield | 0.73% | 0.12% | 0.15% | 2.29% | 2.07% | 5.54% |
| Capitalization / Revenue | 4.29 x | 5.72 x | 4.52 x | 6.14 x | 5.03 x | 3.51 x |
| EV / Revenue | 4.89 x | 6.43 x | 5.09 x | 5.1 x | 4.69 x | 3.34 x |
| EV / EBITDA | 20 x | 23.5 x | 27.1 x | 32.6 x | 15.8 x | 8.26 x |
| EV / FCF | 40.7 x | -9.89 x | 67.4 x | 124 x | -271 x | 215 x |
| FCF Yield | 2.46% | -10.1% | 1.48% | 0.81% | -0.37% | 0.47% |
| Price to Book | 2.35 x | 1.74 x | 1.44 x | 2.06 x | 2.66 x | 1.48 x |
| Nbr of stocks (in thousands) | 217,936 | 323,069 | 323,069 | 343,619 | 308,987 | 307,684 |
| Reference price 2 | 13.75 | 16.37 | 13.70 | 21.80 | 24.20 | 18.04 |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 4/26/22 | 4/26/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 698.3 | 924.4 | 978.5 | 1,220 | 1,486 | 1,583 |
| EBITDA 1 | 170.2 | 252.4 | 183.6 | 190.8 | 440 | 639.7 |
| EBIT 1 | 132.2 | 210.7 | 130.2 | 135.2 | 381.4 | 571.4 |
| Operating Margin | 18.93% | 22.8% | 13.31% | 11.08% | 25.67% | 36.08% |
| Earnings before Tax (EBT) 1 | 105.3 | 158.8 | 67.02 | 402.9 | 388.5 | 585.4 |
| Net income 1 | 89.55 | 122.8 | 44.57 | 293.1 | 291.5 | 493 |
| Net margin | 12.82% | 13.28% | 4.56% | 24.02% | 19.62% | 31.14% |
| EPS 2 | 0.4100 | 0.4500 | 0.1400 | 0.8800 | 0.8500 | 1.520 |
| Free Cash Flow 1 | 83.78 | -600.9 | 73.94 | 50.31 | -25.77 | 24.6 |
| FCF margin | 12% | -65% | 7.56% | 4.12% | -1.73% | 1.55% |
| FCF Conversion (EBITDA) | 49.21% | - | 40.28% | 26.37% | - | 3.85% |
| FCF Conversion (Net income) | 93.56% | - | 165.88% | 17.16% | - | 4.99% |
| Dividend per Share 2 | 0.1000 | 0.0200 | 0.0200 | 0.5000 | 0.5000 | 1.000 |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 4/26/22 | 4/26/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | 415 | 656 | 554 | - | - | - |
| Net Cash position 1 | - | - | - | 1,265 | 504 | 265 |
| Leverage (Debt/EBITDA) | 2.44 x | 2.6 x | 3.02 x | - | - | - |
| Free Cash Flow 1 | 83.8 | -601 | 73.9 | 50.3 | -25.8 | 24.6 |
| ROE (net income / shareholders' equity) | 7.03% | 5.81% | 1.07% | 8.67% | 8.75% | 14.6% |
| ROA (Net income/ Total Assets) | 3.88% | 4.05% | 1.95% | 2.08% | 6.28% | 9.24% |
| Assets 1 | 2,309 | 3,030 | 2,284 | 14,114 | 4,639 | 5,339 |
| Book Value Per Share 2 | 5.850 | 9.430 | 9.530 | 10.60 | 9.080 | 12.20 |
| Cash Flow per Share 2 | 1.160 | 0.8800 | 0.5100 | 3.600 | 1.580 | 1.000 |
| Capex 1 | 124 | 142 | 99.2 | 228 | 266 | 378 |
| Capex / Sales | 17.81% | 15.4% | 10.14% | 18.71% | 17.9% | 23.87% |
| Announcement Date | 4/25/19 | 4/29/20 | 4/28/21 | 4/26/22 | 4/26/23 | 4/25/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +23.00% | 944M | |
| +16.91% | 66.22B | |
| +1.64% | 49.24B | |
| +16.70% | 41.4B | |
| +21.48% | 26.62B | |
| +12.92% | 19.84B | |
| +2.79% | 17.44B | |
| -23.54% | 15.57B | |
| -6.24% | 15.92B | |
| +2.52% | 15.45B |
- Stock Market
- Equities
- 300109 Stock
- Financials Boai NKY Medical Holdings Ltd.